NEWS
![[Pharmnews] C&R Research Received The ‘Innovative CRO’ Certification From Korea National Enterprise For Clinical Trials (KoNECT)](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Pharmnews] C&R Research received the ‘Innovative CRO’ certification from Korea National Enterprise for Clinical Trials (KoNECT)
2023-12-20
C&R Research received the 'Innovative CRO' certification with the highest score ever in the professional areas of 'Project Management' and…
[Medipana] C&R Research achieves a new performance record in the third quarter… Continued operating profit surplus
2023-11-14
C&R Research, a contract research organization (CRO), has achieved a new performance record in the third quarter and continues to…
[Hankyung] C&R Research, ‘Highest score ever’ in Korea National Enterprise for Clinical Trials (KoNECT) evaluation report
2023-11-07
C&R Research, a domestic contract research organization (CRO), received the highest score ever, breaking existing records in major items of…
[Etoday] C&R Research “Neurobiogen obesity treatment, U.S. FDA Pre-IND application”
2023-09-25
C&R Research announced on the 25th that it has decided to submit a Phase 2 Pre-IND (pre-meeting) application to the…
[Etoday] C&R Research conducts global clinical trials for Shaperon atopic dermatitis treatment ‘NuGel’
2023-09-18
C&R Research announced on the 18th that it has decided to conduct a global clinical trial with Shaperon and InHandPlus.…